APA (7th ed.) Citation

Wang, H., Jin, Y., Liu, P., Zhou, J., Fan, N., & Li, M. Immune checkpoint inhibitor-related pneumonitis following discontinuation of pembrolizumab in a patient with advanced lung adenocarcinoma: A case report and literature review. BMC.

Chicago Style (17th ed.) Citation

Wang, Huan, Yuzhen Jin, Peng Liu, Jie Zhou, Na Fan, and Mengjie Li. Immune Checkpoint Inhibitor-related Pneumonitis Following Discontinuation of Pembrolizumab in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review. BMC.

MLA (9th ed.) Citation

Wang, Huan, et al. Immune Checkpoint Inhibitor-related Pneumonitis Following Discontinuation of Pembrolizumab in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review. BMC.